Indonesia Oncology Clinical Trials Market Analysis

Indonesia Oncology Clinical Trials Market Analysis


$ 3999

Indonesia's oncology clinical trials market is projected to grow from $75.9 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. The market will be driven by the increasing need for innovative and effective therapies with the rising incidence of cancers and increased investments in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Kalbe Farma.

ID: IN10IDCT006 CATEGORY: Clinical Trials GEOGRAPHY: Indonesia AUTHOR: Vidhi Upadhyay

Buy Now

Indonesia Oncology Clinical Trials Market Executive Summary

Indonesia's oncology clinical trials market is projected to grow from $75.9 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. Indonesia is a nation comprised of about 17,000 islands, around 8000 of which are inhabited, with a population of almost 250 Mn people and 300 languages, making it the fourth most populated country in the world. Indonesia has a strong economy, a growing middle class, and a rapidly urbanising population. In Indonesia, 614 trials were registered, including 92 active research. According to Globocan 2020, In Indonesia, the incidence of cancer was found to be 3,96,914 and 2,34,511 fatalities were recorded.

Participation in oncology clinical trials has expanded in recent years in the country, with a focus on illnesses such as breast cancer, lung cancer, colorectal cancer, lymphoma, paediatric cancers and leukaemia. The number of local and international pharmaceutical companies and research organisations conducting trials in the country has increased, making it an important centre for oncology clinical trials. These studies are designed to assess the safety and effectiveness of novel medications or therapies for cancer patients.

The National Agency of Drug and Food Control (BPOM) and the Ministry of Health regulate the regulatory framework for clinical trials in Indonesia. The approval procedure for a clinical experiment may be time-consuming and comprises numerous levels of evaluation. The expansion of oncology clinical trials in Indonesia is encouraging, but more efforts are required to tackle constraints such as limited resources and patient involvement. To advance the area of oncology clinical trials in Indonesia, further investment in healthcare infrastructure, research skills, and patient education is required.

indonesia oncology clinical trials market analysis

Market Dynamics

Market Growth Drivers

Many main variables are driving the increase in oncology clinical trials in Indonesia. Cancer is becoming more common in the nation, increasing the need for innovative and effective therapies. The Indonesian government has made efforts to encourage clinical trials and to create the infrastructure and talent required to support them. International collaboration has aided in the promotion and support of oncology clinical trials in the country. In certain regions, improving patient knowledge and engagement in clinical trials has resulted in greater trial enrolment. Lastly, Indonesia's huge and diversified patient population makes it an appealing place for conducting clinical trials, especially in the fields of breast cancer and leukaemia.

Market Restraints

One barrier to conducting oncology clinical trials in Indonesia is the lack of research infrastructure and resources. Many hospitals and clinics lack the requisite equipment and competence to perform extensive trials, and competent researchers and clinical trial coordinators are in limited supply. Another barrier is a lack of patient understanding and involvement in clinical trials. Many Indonesians may be unaware of clinical trials' existence or possible advantages, and cultural ideas and attitudes towards medical research might also be a barrier.

Competitive Landscape

Key Players

  • Pfizer Inc.
  • Novartis International AG
  • AstraZeneca plc
  • Roche Holding AG
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Sanofi S.A.
  • Bristol Myers Squibb Company
  • Kalbe Farma (IDN)
  • Tempo Scan Pacific (IDN)
  • Kimia Farma (IDN)

Notable Insights

  1. January 2023, Indonesia has launched three programmes to improve cancer treatment. Project Extension for Community Healthcare Outcomes (ECHO), Cancer Patient Navigation (NAPAK), and a capacity-building initiative for oncology nurses
  2. In November 2022, The Tata Memorial Foundation will train cancer patient navigators in Indonesia. As part of the Department of Atomic Energy, Government of India's Cancer Vishwam Program, the hospital developed a relationship with Roche Indonesia and the Indonesian government. It aspires to assist other developing nations in cancer care capacity-building, knowledge-sharing, and skill development.
  3. February 2021, Kalbe of Indonesia secures a $1.1 billion contract with Genexine of South Korea for COVID and a cancer drug candidate

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Clinical Trials Regulation in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation

6. Methodology and Scope

Oncology Clinical Trials Market Segmentation

By Phase (Revenue, USD Billion):

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By Study Design Outlook (Revenue, USD Billion):

  • Epilepsy
  • Parkinson's Disease (PD)
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury (TBI)
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscle regeneration
  • Others

By Indication Outlook  (Revenue, USD Billion):

  • Interventional
  • Observational
  • Expanded Access

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 June 2023
Updated by: Jay Dalwadi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up